Riggs Josh 4
4 · Oncocyte Corp · Filed Aug 17, 2023
Insider Transaction Report
Form 4
Riggs Josh
CEO and President
Transactions
- Award
Option to Purchase Common Stock
2023-08-15+40,000→ 40,000 totalExercise: $3.34Exp: 2033-08-15→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The options will vest and thereby be exercisable on December 31, 2025, based on achievement of certain specified targets with respect to the 30-day volume-weighted average price of Company's common stock, measured as of the end of each full calendar month up through December 31, 2025, subject to continuous services through December 31, 2025.